But what we wanted to understand is what theyre doing in the brain. Key findings GLP-1 drugs act not only on metabolic pathways but also on brain circuits linked to reward Researchers identified a pathway connecting the hindbrain, central amygdala and dopamine-producing neurons The drugs reduce not just hunger, but the desire for high-calorie, rewarding foods Findings may help explain both therapeutic benefits and side effects such as nausea or reduced pleasure Beyond appetite suppression GLP-1 receptor agonists were originally developed to treat Type 2 diabetes by improving insulin response, with weight loss emerging as a secondary benefit
Oral semaglutide has shown significant potential in helping individuals manage their weight
Healthletic BPC-157 is intended to support natural processes, not to replace medical care
Whole grains, berries, carrots, broccoli, and oats are all simple ways to add fiber to your meals
Depending on your needs and preferences, you can choose to treat a specific body area or your entire body